| |
| |
REVIEW
|
| |
Prophylaxis of skeletal complications of bone metastases or multiple myeloma
|
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
Discount contracts: consequences for patients
Autologous blood therapy ORTHOKIN: what´s new?
|
| |
| |
IN BRIEF
|
| |
Drospirenone-containing pill YAZ not additionally approved against acne
Pharmaceutical industry spends up to 91 million € per year for lobbying in the EU
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Lymphoma with natalizumab (TYSABRI)
|
 |
Polyneuropathy and visual disturbance with dronedarone (MULTAQ) |
| |
| |
SIDE EFFECTS
|
| |
Preventing accidental poisoning with opioid patches
Retinal detachment with gyrase inhibitors
|
| |